CNMD - CONMED Corp

QQQ $ 422.80 $ -2.43 (-0.57 %)

DIA $ 377.76 $ 0.39 (0.1 %)

SPY $ 499.54 $ -1.03 (-0.21 %)

TLT $ 88.82 $ -0.45 (-0.5 %)

GLD $ 220.32 $ 0.75 (0.34 %)

Previous Close

$ 71.08

Open

$ 72.26

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 70.61 - $ 72.46

52 Week Range

$ 70.57 - $ 137.65

Volume

622,688

Average Volume

Market Cap

2.19B

Beta (5Y Monthly)

$ 1.58

PE Ratio (TTM)

$ 33.94

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-28-2024	12-31-2023	10-K
2	10-26-2023	09-30-2023	10-Q
3	07-27-2023	06-30-2023	10-Q
4	04-27-2023	03-31-2023	10-Q
5	02-21-2023	12-31-2022	10-K
6	10-27-2022	09-30-2022	10-Q
7	07-28-2022	06-30-2022	10-Q
8	05-05-2022	03-31-2022	10-Q
9	02-22-2022	12-31-2021	10-K
10	10-28-2021	09-30-2021	10-Q
11	07-29-2021	06-30-2021	10-Q
12	04-29-2021	03-31-2021	10-Q
13	02-22-2021	12-31-2020	10-K
14	10-29-2020	09-30-2020	10-Q
15	07-30-2020	06-30-2020	10-Q
16	04-30-2020	03-31-2020	10-Q
17	02-24-2020	12-31-2019	10-K
18	10-31-2019	09-30-2019	10-Q
19	08-01-2019	06-30-2019	10-Q
20	04-26-2019	03-31-2019	10-Q
21	02-25-2019	12-31-2018	10-K
22	11-02-2018	09-30-2018	10-Q
23	08-02-2018	06-30-2018	10-Q
24	04-26-2018	03-31-2018	10-Q
25	02-26-2018	12-31-2017	10-K
26	11-02-2017	09-30-2017	10-Q
27	07-27-2017	06-30-2017	10-Q
28	04-27-2017	03-31-2017	10-Q
29	02-27-2017	12-31-2016	10-K
30	10-28-2016	09-30-2016	10-Q
31	07-28-2016	06-30-2016	10-Q
32	05-02-2016	03-31-2016	10-Q
33	02-23-2016	12-31-2015	10-K
34	10-23-2015	09-30-2015	10-Q
35	07-27-2015	06-30-2015	10-Q
36	04-24-2015	03-31-2015	10-Q
37	02-23-2015	12-31-2014	10-K
38	10-24-2014	09-30-2014	10-Q
39	07-25-2014	06-30-2014	10-Q
40	04-25-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cracking The Code: Understanding Analyst R...
02/01/2024 21:00:36

Piper Sandler Maintains Overweight on Conm...
02/01/2024 20:18:48

Piper Sandler analyst Matt O'Brien maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $130 ...

JP Morgan Maintains Overweight on Conmed, ...
02/01/2024 14:40:35

JP Morgan analyst Robbie Marcus maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $135 to $115.

these-analysts-revise-their-forecasts-on-conmed-after-q4-results

These Analysts Revise Their Forecasts On C...
02/01/2024 13:42:33

CONMED Corporation (NYSE: CNMD) reported weaker-than-expected fourth-quarter financial results on Wednesday.

Wells Fargo Maintains Equal-Weight on Conm...
02/01/2024 13:27:14

Wells Fargo analyst Durgesh Chopra maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $107 to...

AT&T To Rally Around 19%? Here Are 10 Top ...
02/01/2024 12:48:20

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Needham Maintains Buy on Conmed, Raises Pr...
02/01/2024 12:22:13

Needham analyst Mike Matson maintains Conmed (NYSE:CNMD) with a Buy and raises the price target from $119 to $129.

Recap: Conmed Q4 Earnings
01/31/2024 21:15:20

Conmed Q4 Adj EPS $1.06 Misses $1.11 Estim...
01/31/2024 21:13:35

Conmed (NYSE:CNMD) reported quarterly earnings of $1.06 per share which missed the analyst consensus estimate of $1.11 by 4.5 p...

Earnings Scheduled For January 31, 2024
01/31/2024 11:09:37

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue...

Conmed's Earnings: A Preview
01/30/2024 18:01:58

Stifel Maintains Buy on Conmed, Lowers Pri...
10/26/2023 19:27:49

Stifel analyst Rick Wise maintains Conmed (NYSE:CNMD) with a Buy and lowers the price target from $136 to $120.

Piper Sandler Maintains Overweight on Conm...
10/26/2023 18:54:37

Piper Sandler analyst Matt O'Brien maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $145 ...

Wells Fargo Maintains Equal-Weight on Conm...
10/26/2023 12:56:21

Wells Fargo analyst Durgesh Chopra maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $123 to...

Needham Maintains Buy on Conmed, Lowers Pr...
10/26/2023 09:33:34

Needham analyst Mike Matson maintains Conmed (NYSE:CNMD) with a Buy and lowers the price target from $140 to $119.

Conmed Q3 EPS $0.90 Beats $0.83 Estimate, ...
10/25/2023 20:24:22

Conmed (NYSE:CNMD) reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.83 by 8.43 pe...

Earnings Scheduled For October 25, 2023
10/25/2023 11:32:40

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on ...

Conmed's Earnings: A Preview
10/24/2023 18:01:23

JP Morgan Maintains Overweight on Conmed, ...
07/27/2023 13:55:50

JP Morgan analyst Robbie Marcus maintains Conmed (NYSE:CNMD) with a Overweight and raises the price target from $125 to $145.

Needham Maintains Buy on Conmed, Raises Pr...
07/27/2023 09:41:39

Needham analyst Mike Matson maintains Conmed (NYSE:CNMD) with a Buy and raises the price target from $139 to $140.

CLASS ACTION DEADLINES - JOIN NOW!

04/22/2024 Dick's Sporting Goods, Inc. (DKS)

04/22/2024 Innodata Inc. (INOD)

04/22/2024 Fox Factory Holding Corp. (FOXF)

04/23/2024 Lantronix, Inc. (LTRX)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)

CNMDCONMED Corp

NYSE conmed.com

$ 71.12 $ -1.68 (-2.31 %)

Thursday, 18-Apr-2024 15:59:54 EDT